In the News

More so now than ever, the inclusion of more diverse, and often more relevant, study populations is gathering momentum within the clinical trial community.

ICON is awarded the Best Irish Company in France 2021, recognising the significant contribution our French colleagues have made to our business in France and globally.

In this video interview, Kim Boericke, President, Commercialization and Outcomes Services, discusses what is driving a great focus and intensity on outcomes in clinical trials, trends coming in 2022, and the use of real-world data in the rare disease space.

This article by Dr. Peter Schueler explores how digital and liquid biomarkers are developing, and how they can impact the future of neurological studies.

An article reporting on ICON's recent announcement that its Accellacare Site Network has entered new partnerships with six research sites across four countries, expanding its global footprint and capabilities.

This article highlights the expansion of the Accellacare site network and how it will increase access and engagement with investigative sites and their patients.

Mitsu Rana, Senior Director of Project Management, share her perspective on the current state of clinical research and how it is adapting.

Nicole A. Cowan explores how glycomics is joining genomics and proteomics in the study of disease mechanisms and the development of novel therapeutics.

Michael Phillips and Kevin Rooney discuss the use of artificial intelligence for the purposes of automation in digital health and pharma.

The evening was particularly successful for ICON plc, which won the coveted Clinical Research Company of the Year award for having the most successful finalists throughout the competition.